Valiant Laboratories Ltd.

Financial

	Valiant Laboratories	Albert David	Chandan Healthcare
Operational Metrics
Financials
5 yr Average ROE	22.49 %	12.32 %	12.89 %
5yr average Equity Multiplier	2.04	1.67	3.38
5yr Average Asset Turnover Ratio	1.23	0.67	1.41
5yr Avg Net Profit Margin	6.1 %	11.52 %	3.01 %
Price to Book	2.0	1.16	0.0
P/E	0.0	26.52	20.89
5yr Avg Cash Conversion Cycle	77.97 Days	-59.38 Days	-66.59 Days
Inventory Days	19.05 Days	46.72 Days	23.67 Days
Days Receivable	134.62 Days	28.39 Days	51.93 Days
Days Payable	71.52 Days	118.01 Days	184.38 Days
5yr Average Interest Coverage Ratio	238.24	90.39	4.08
5yr Avg ROCE	18.33 %	15.83 %	19.88 %
5yr Avg Operating Profit Margin	6.8 %	11.27 %	7.87 %
5 yr average Debt to Equity	0.59	0.01	0.83
5yr CAGR Net Profit	-58.96 %	31.51 %	n/a
5yr Average Return on Assets	9.61 %	7.45 %	4.05 %
Shareholdings
Promoter Holding	74.94 %	62.24 %	49.43 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	0.0	0.28 %	0.0
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	0.0

Business

	Valiant Laboratories	Albert David	Chandan Healthcare
Product Wise Break-Up	Product Wise Break-Up Paracetamol 100.0 Pharmaceuticals 0 Radiology 0 Pathology 0 Surgical 0 FMCG 0	Product Wise Break-Up FMCG 0 Paracetamol 0 Pharmaceutical 100.0 Pathology 0 Radiology 0 Surgical 0	Product Wise Break-Up FMCG 9.9 Paracetamol 0 Pharmaceuticals 34.16 Pathology 34.22 Radiology 18.77 Surgical 2.94 Others 0.01
Location Wise Break-Up	Location Wise Break-Up India 99.49 Rest of the World 0 Others 0.51	Location Wise Break-Up Rest of the World 7.21 India 92.79	-
Asset Break-Up - Geography Wise	Asset Break-Up - Geography Wise India 100.0	-	-